C-Met, CREB1 and EGFR Are Involved in Mir-493-5p Inhibition of EMT Via AKT/GSK-3β/Snail Signaling in Prostate Cancer

Song Wang,Xiao Wang,Jiangfeng Li,Shuai Meng,Zhen Liang,Xin Xu,Yi Zhu,Shiqi Li,Jian Wu,Mingjie Xu,Alin Ji,Yiwei Lin,Ben Liu,Xiangyi Zheng,Bo Xie,Liping Xie
DOI: https://doi.org/10.18632/oncotarget.19398
2017-01-01
Oncotarget
Abstract:miR-493-5p downregulation has emerged as a critical player in cancer progression yet, the underlying mechanisms of miR-493-5p expression pattern and its function in prostate cancer remains to be elucidated. Here, we illustrate that miR-493-5p is frequently downregulated in prostate cancer, at least partially due to altered DNA methylation. miR-493-5p functions as a tumor suppressor in prostate cancer cells. c-Met, CREB1 and EGFR are downstream target genes of miR-493-5p. miR-493-5p inhibits EMT via AKT/GSK-3β/Snail signaling in prostate cancer. Taken together, our study identified c-Met, CREB1, EGFR and miR-493-5p establish a regulatory loop in prostate cancer, which could prove useful in the development of effective and therapies against prostate cancer.
What problem does this paper attempt to address?